Strong Ph2 Data For PDE10A Inhibitor CPL36 In Parkinson’s Dyskinesia
04 Mar 2025 //
GLOBENEWSWIRE
Poland`s Celon Pharma sees schizophrenia drug as `billion-dollar` product
10 Jul 2024 //
REUTERS
Celon Pharma Announces Results Of Phase II Clinical Trial For CPL’ 116 In RA
17 Jun 2024 //
GLOBENEWSWIRE